-
Application for (2R, 4R)-1,2,4-trihydroxyheptadec-16-yne in preparation of pharmaceutical composition for preventing or treating hepatic injury
申请人:KAOHSIUNG MEDICAL UNIVERSITY
公开号:US11413254B2
公开(公告)日:2022-08-16
The present invention provides a use of (2R,4R)-1,2,4-trihydroxy heptadec-16-yne or a pharmaceutically acceptable salt, a tautomer, a stereoisomer or an enantiomer thereof in the preparation of a pharmaceutical composition for preventing or treating liver injury.
本发明提供了(2R,4R)-1,2,4-三羟基十七-16-炔或其药学上可接受的盐、同系物、立体异构体或对映体在制备预防或治疗肝损伤的药物组合物中的用途。
-
[EN] APPLICATION OF AVOCADO EXTRACT, AVOCADENOL B, AND (2R,4R)-1,2,4-TRIHYDROXY HEPTADEC-16-YNE, AND HEALTH FOOD COMPRISING AVOCADO EXTRACT<br/>[FR] APPLICATION D'EXTRAIT D'AVOCAT, D'AVOCADENOL B ET DE (2R,4R)-1,2,4-TRIHYDROXY HEPTADEC-16-YNE, ET ALIMENT SANTÉ COMPRENANT L'EXTRAIT D'AVOCAT<br/>[ZH] 酪梨萃取物、avocadenol B及(2R,4R)-1,2,4-三羟基十七碳-16-炔的用途,以及包含酪梨萃取物的保健食品
申请人:UNIV KAOHSIUNG MEDICAL
公开号:WO2017063150A1
公开(公告)日:2017-04-20
本发明公开了酪梨萃取物用于制备预防黄热病毒科病毒感染的保健食品或食物添加物的用途。本发明也提供了avocadenol B和(2R,4R)-1,2,4-三羟基十七碳-16-炔用于制备治疗或预防黄热病毒科病毒感染的药物的用途。本发明更提供一种抑制黄热病毒科病毒复制活性或病毒性发炎反应的保健食品,包括有效量的酪梨萃取物为活性成分以及医药学上可接受的载剂。
-
[EN] APPLICATION FOR (2R, 4R)-1,2,4-TRIHYDROXYHEPTADEC-16-YNE IN PREPARATION OF PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING HEPATIC INJURY<br/>[FR] APPLICATION DE (2R,4R)-1,2,4-TRIHYDROXYHEPTADÉC-16-YNE DANS LA PRÉPARATION D'UNE COMPOSITION PHARMACEUTIQUE PERMETTANT DE PRÉVENIR OU DE TRAITER UNE LÉSION HÉPATIQUE<br/>[ZH] (2R,4R)-1,2,4-三羟基十七碳-16-炔在制备预防或治疗肝损伤医药组合物中的应用
申请人:UNIV KAOHSIUNG MEDICAL
公开号:WO2018112816A1
公开(公告)日:2018-06-28
本发明提供了(2R,4R)-1,2,4-三羟基十七碳-16-炔或其医药学上可接受的盐,互变异构体,立体异构体或对映异构体在制备预防或治疗肝损伤的医药组合物中的用途。
-
BECKER, D.;SAHALI, Y.;RAVIV, M., PHYTOCHEMISTRY, 29,(1990) N, C. 2065-2067
作者:BECKER, D.、SAHALI, Y.、RAVIV, M.
DOI:——
日期:——
-
APPLICATION FOR (2R, 4R)-1,2,4-TRIHYDROXYHEPTADEC-16-YNE IN PREPARATION OF PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING HEPATIC INJURY
申请人:KAOHSIUNG MEDICAL UNIVERSITY
公开号:US20200230075A1
公开(公告)日:2020-07-23
The present invention provides a use of (2R,4R)-1,2,4-trihydroxy heptadec-16-yne or a pharmaceutically acceptable salt, a tautomer, a stereoisomer or an enantiomer thereof in the preparation of a pharmaceutical composition for preventing or treating liver injury.